APPLIED THERAPEUTICS INC (APLT) Stock Analyst Ratings
NASDAQ:APLT • US03828A1016
0.103 USD
+0 (+0.19%)
At close: Feb 2, 2026
0.1051 USD
+0 (+2.04%)
After Hours: 2/2/2026, 8:00:00 PM
ChartMill assigns a Buy % Consensus number of 49% to APLT. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 0.26. This target is 147.57% above the current price.
- APLT was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about APLT.
- In the previous month the buy percentage consensus was at a similar level.
- APLT was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-03 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-05-14 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-12-23 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-12-20 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-12-02 | UBS | Downgrade | Buy -> Neutral |
| 2024-11-29 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-11-29 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-29 | Citigroup | Maintains | Buy -> Buy |
| 2024-09-19 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-09-19 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-27 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-31 | William Blair | Initiate | Outperform |
| 2024-07-17 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-04-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-26 | RBC Capital | Initiate | Outperform |
| 2024-03-15 | UBS | Maintains | Buy -> Buy |
| 2024-03-06 | UBS | Maintains | Buy -> Buy |
| 2024-02-22 | Leerink Partners | Initiate | Outperform |
| 2024-02-16 | Citigroup | Maintains | Buy -> Buy |
| 2023-04-25 | Baird | Maintains | Outperform |
| 2023-04-05 | Citigroup | Maintains | Buy |
| 2022-08-17 | Citigroup | Maintains | Buy |
| 2022-08-16 | Barclays | Maintains | Equal-Weight |
| 2022-05-20 | Citigroup | Maintains | Buy |
| 2022-01-04 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2021-08-27 | Goldman Sachs | Downgrade | Neutral -> Sell |
APPLIED THERAPEUTICS INC / APLT FAQ
Can you provide the average price target for APPLIED THERAPEUTICS INC stock?
9 analysts have analysed APLT and the average price target is 0.26 USD. This implies a price increase of 147.57% is expected in the next year compared to the current price of 0.103.
What is the consensus rating for APLT stock?
The consensus rating for APPLIED THERAPEUTICS INC (APLT) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.